inclusion criteria: 1. recruited subjects include adult subjects ≥18 years 2. immunocompromised subjects as defined by the following. 1. patients who have undergone solid organ or stem cell transplantation and on immunosuppressive medication. 2. patients who are on chemotherapy, biologics or other immunosuppressive therapy. 3. patients who are on high-dose corticosteroid (prednisolone 0.5mg/kg daily or equivalent) 3. negative igg antibody response against covid19 14 days after the second dose of covid19 vaccination. 4. all subjects have to give written informed consent. 5. subjects must be available to complete the study and comply with study procedures. willingness to allow for serum samples to be stored beyond the study period, for potential additional future testing to better characterize immune response

inclusion criteria: 1. recruited subjects include adult subjects ≥18 years 2. immunocompromised subjects as defined by the following. 1. patients who have undergone solid organ or stem cell transplantation and on immunosuppressive medication. 2. patients who are on chemotherapy, biologics or other immunosuppressive therapy. 3. patients who are on high-dose corticosteroid (prednisolone 0.5mg/kg daily or equivalent) 3. negative igg antibody response against covid19 14 days after the second dose of covid19 vaccination. 4. all subjects have to give written informed consent. 5. subjects must be available to complete the study and comply with study procedures. willingness to allow for serum samples to be stored beyond the study period, for potential additional future testing to better characterize immune response

inclusion criteria: recruited subjects include adult subjects ≥18 years immunocompromised subjects as defined by the following. patients who have undergone solid organ or stem cell transplantation and on immunosuppressive medication. patients who are on chemotherapy, biologics or other immunosuppressive therapy. patients who are on high-dose corticosteroid (prednisolone 0.5mg/kg daily or equivalent) negative igg antibody response against covid19 14 days after the second dose of covid19 vaccination. all subjects have to give written informed consent. subjects must be available to complete the study and comply with study procedures. willingness to allow for serum samples to be stored beyond the study period, for potential additional future testing to better characterize immune response

inclusion criteria: recruited subjects include adult subjects ≥18 years immunocompromised subjects as defined by the following. patients who have undergone solid organ or stem cell transplantation and on immunosuppressive medication. patients who are on chemotherapy, biologics or other immunosuppressive therapy. patients who are on high-dose corticosteroid (prednisolone 0.5mg/kg daily or equivalent) negative igg antibody response against covid19 14 days after the second dose of covid19 vaccination. all subjects have to give written informed consent. subjects must be available to complete the study and comply with study procedures. willingness to allow for serum samples to be stored beyond the study period, for potential additional future testing to better characterize immune response